Simulation studies for binding affinity prediction, ADMET screening, and lead optimisation, reducing attrition before you enter the wet lab.
Grab a scoping callWe run simulation studies that score and rank compounds before you commit to synthesis. Binding free energies, ADMET properties, and metabolic liabilities are computed at chemical accuracy, so your medicinal chemistry team synthesises the right molecules first, not the obvious ones.
Computationally screening molecules against intended targets to eliminate low-probability candidates before synthesis.
Predicting severe side effects, including cardiac toxicity and hepatotoxicity, before clinical trials begin.
We'll scope a study within 48 hours and tell you whether our platform can help. No commitment required.
Grab a scoping callor email [email protected]